Umbilical Cord Blood-derived Mesenchymal Stem Cells in Regeneration of Sweat Glands and Body Repair

Sweat Gland Diseases Clinical Trial

Official title:

Umbilical Cord Blood-derived Mesenchymal Stem Cells in Regeneration of Sweat Glands and Body Repair

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT02304562
• Other study ID #: CHIN-PLAGH-ST-004
• Status: Recruiting
• Phase: Phase 1
• First received: November 21, 2014
• Last updated: December 1, 2014
• Start date: January 2013
• Est. completion date: December 2017

Study information

• Verified date: November 2014
• Source: Chinese PLA General Hospital
• Contact: xiaobing FU
• Phone: +86(10)937516
• Is FDA regulated: No
• Health authority: China: Ethics Committee
• Study type: Interventional

Clinical Trial Summary

Patients with skin injury treated with Umbilical Cord Blood-derived Mesenchymal Stem Cells,such as deep burn damaged sweat glands,Effectiveness of Umbilical Cord Blood-derived Mesenchymal Stem Cells in Regeneration of Sweat Glands and Body Repair is determined.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 50
• Est. completion date: December 2017
• Est. primary completion date: December 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 60 Years

Eligibility

Inclusion Criteria:

• Burn area:10-20%TBSA

Exclusion Criteria:

• Have influence on the speed of wound healing of patients with chronic diseases

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Sweat Gland Diseases

Intervention

Biological:
• UCB Mesenchymal Stem Cells treatment
reduce skin injury

Locations

Country	Name	City	State
China	Chinese PLA General Hospital	Beijing	Beijing

Sponsors (1)

Lead Sponsor	Collaborator
Chinese PLA General Hospital

Country where clinical trial is conducted

China, 

References & Publications (1)

Fu X, Qu Z, Sheng Z. Potentiality of mesenchymal stem cells in regeneration of sweat glands. J Surg Res. 2006 Dec;136(2):204-8. Epub 2006 Oct 20. Review. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Frequency of Adverse Events	Frequency and severity of Adverse Events	6 months	Yes
Secondary	Active and inactive lesion count		6 months	Yes